Page last updated: 2024-12-07

1-(9-fluorenyl)ethyl chloroformate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-(9-Fluorenyl)ethyl Chloroformate: A Versatile Reagent for Peptide Synthesis

1-(9-Fluorenyl)ethyl chloroformate (Fmoc-Cl) is a **key reagent in peptide synthesis**, specifically in the **solid-phase peptide synthesis (SPPS)** method. It's a crucial component because it allows for the **protection and deprotection** of amino acids during the synthesis process.

**Here's why Fmoc-Cl is important:**

* **Protection:** Fmoc-Cl reacts with the **amino group** of an amino acid, forming a **Fmoc-protected amino acid**. This protection prevents unwanted side reactions during the synthesis process.
* **Deprotection:** The Fmoc group can be selectively removed using **piperidine**, a base, under mild conditions. This allows for the addition of the next amino acid to the growing peptide chain without affecting the previously added amino acids.
* **Orthogonality:** The Fmoc protection strategy is **orthogonal** to other commonly used protecting groups in peptide synthesis, allowing for the **sequential addition of different amino acids** with different protection strategies.
* **Efficiency:** The Fmoc/piperidine system provides a **high yield and high purity** in peptide synthesis, making it a highly efficient method.

**Fmoc-Cl is widely used in research for various applications, including:**

* **Developing new therapeutic peptides:** Fmoc-Cl helps synthesize peptides with specific sequences and properties for use in drug development.
* **Studying protein structure and function:** Synthesized peptides can be used to investigate protein interactions and enzymatic activity.
* **Producing biomaterials and biocompatible polymers:** Fmoc-Cl is used to synthesize peptides for use in various materials science applications.

**Overall, Fmoc-Cl is a fundamental tool in peptide synthesis research, enabling the efficient synthesis of complex and diverse peptide molecules for various scientific applications.**

1-(9-fluorenyl)ethyl chloroformate: chiral reagent; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115102
SCHEMBL ID1876853
MeSH IDM0149797

Synonyms (20)

Synonym
flec
1-(9h-fluoren-9-yl)ethyl carbonochloridate
SCHEMBL1876853
(+)-1-(9h-fluoren-9-yl)ethyl carbonochloridate
1-(9-fluorenyl)ethyl chloroformate
107474-79-3
carbonochloridic acid, 1-(9h-fluoren-9-yl)ethyl ester, (+)-
(+)-1-(9-fluorenyl)ethyl chloroformate
105764-39-4
154479-90-0
118609-65-7
J-001903
J-009108
DTXSID00910337
FT-0706990
FT-0738928
(-)-1-(9h-fluoren-9-yl)ethyl carbonochloridate
1-(9-fluorenyl)ethylchloroformate
STARBLD0002164
(-)-1-(9-fluorenyl)ethyl chloroformate solution - 18mm in acetone, for chiral derivatization
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (14.29)18.7374
1990's10 (47.62)18.2507
2000's3 (14.29)29.6817
2010's5 (23.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.88 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]